Déjà vu in the laboratory: a behavioral and experiential comparison of posthypnotic amnesia and posthypnotic familiarity

The International Journal of Clinical and Experimental Hypnosis
Akira R O'ConnorRochelle E Cox

Abstract

This experiment aimed to create a laboratory analogue of déjà vu. During hypnosis, 1 group of high hypnotizables completed a puzzle game and then received a posthypnotic amnesia suggestion to forget the game (PHA condition). Another group of highs were not given the game but received a posthypnotic familiarity suggestion that it would feel familiar (PHF condition). After hypnosis, all participants were given the game and described their reactions to it. Whereas 83% of participants in both conditions passed their respective suggestions, more in the PHF condition felt a sense of déjà vu. An EAT inquiry revealed that they experienced sensory fascination and confusion about the source of familiarity, akin to everyday déjà vu. These findings highlight the value of using hypnosis as a laboratory analogue of déjà vu and provide a framework for investigating clinical manifestations of this phenomenon.

References

Oct 1, 1979·Journal of Abnormal Psychology·J F Kihlstrom
Oct 1, 1979·Journal of Abnormal Psychology·F J Evans
Apr 1, 1979·The International Journal of Clinical and Experimental Hypnosis·E R HilgardJ F Kihlstrom
Oct 1, 1978·Journal of Abnormal Psychology·P W SheehanD Cross
Apr 1, 1975·The International Journal of Clinical and Experimental Hypnosis·G S Blum
Nov 1, 1989·Journal of Abnormal Psychology·R A Bryant, K M McConkey
Aug 1, 1989·Journal of Abnormal Psychology·R A Bryant, K M McConkey
Oct 1, 1966·The International Journal of Clinical and Experimental Hypnosis·F J Evans, D Schmeidler
Nov 1, 1967·Archives of General Psychiatry·T F Richardson, G Winokur
Oct 1, 1983·British Journal of Orthodontics·R T Broadway
Jun 26, 1981·Science·P G ZimbardoL G Kabat
Feb 1, 1995·Journal of Abnormal Psychology·J Noble, K M McConkey
Jan 5, 2000·The International Journal of Clinical and Experimental Hypnosis·A J Barnier, K M McConkey
Apr 18, 2000·Lancet·P W HalliganR S Frackowiak
Jun 2, 2000·BMJ : British Medical Journal·P W HalliganD T Wade
Apr 17, 2001·The Behavioral and Brain Sciences·J P Aggleton, M W Brown
Jun 30, 2001·The International Journal of Clinical and Experimental Hypnosis·C BurnK M McConkey
Sep 26, 2001·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·A P Yonelinas
Apr 2, 2003·Neuropsychologia·S-J BlakemoreC D Frith
Jul 1, 1953·The American Journal of Psychiatry·L LINN
May 1, 1959·Journal of Abnormal Psychology·M T ORNE
Jan 1, 1962·The International Journal of Clinical and Experimental Hypnosis·R E SHOR
Oct 1, 1962·The American Journal of Clinical Hypnosis·A M WEITZENHOFFER
Aug 25, 2004·NeuroImage·Stuart W G DerbyshireDavid A Oakley
Sep 17, 2004·The International Journal of Clinical and Experimental Hypnosis·Amanda J BarnierJonathan Wright
Jun 14, 2005·Neuropsychologia·Christopher J A MoulinRoy W Jones
Jul 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Amir RazMichael I Posner
Aug 8, 2006·Brain and Cognition·Akira R O'Connor, Christopher J A Moulin
Dec 5, 2006·Brain : a Journal of Neurology·Jean-Pierre VignalPatrick Chauvel
Mar 18, 2008·Best Practice & Research. Clinical Haematology·Jacob M Rowe
Jul 3, 2008·Psychology and Psychotherapy·Karina Lovell, Penny Bee

❮ Previous
Next ❯

Citations

Apr 29, 2010·Current Psychiatry Reports·Akira R O'Connor, Chris J A Moulin
Jun 14, 2005·Neuropsychologia·Christopher J A MoulinRoy W Jones
Feb 26, 2010·The International Journal of Clinical and Experimental Hypnosis·Michael R NashJacob J Levy
Aug 28, 2010·The International Journal of Clinical and Experimental Hypnosis·Michael R Nash, Anthony Tasso
Nov 22, 2011·The International Journal of Clinical and Experimental Hypnosis·Jillian E AttewellRobyn Langdon
Apr 16, 2010·Cognitive Neuropsychiatry·Akira R O'ConnorChris J A Moulin
May 31, 2011·Cognitive Neuropsychiatry·Alena RahmanovicMax Coltheart
Sep 8, 2012·Epilepsy Research and Treatment·Nathan A IllmanChris J A Moulin
May 16, 2015·The International Journal of Clinical and Experimental Hypnosis·Rochelle E Cox, Amanda J Barnier
Jan 6, 2015·Psychiatry Research·William Jonathan McGeownAnnalena Venneri
Nov 26, 2008·The International Journal of Clinical and Experimental Hypnosis·Rochelle E Cox, Amanda J Barnier
Dec 10, 2016·The International Journal of Clinical and Experimental Hypnosis·Enrico FaccoDavid Spiegel
Aug 24, 2018·Memory·Alexandra ErnstSylvie Willems
Sep 21, 2018·Memory·Josephine A UrquhartAkira R O'Connor
Dec 7, 2019·Journal of Complementary & Integrative Medicine·Coco MarinellaBuscemi Andrea
May 12, 2009·Trends in Cognitive Sciences·David A Oakley, Peter W Halligan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.